R-801

N/A

Report date: 2022/03/02 18:05:10
NME

Base Information

Drug NameR-801
Drug Alias NameR-801
ClassificationSmall molecules
Mechanisms of ActionSuperoxide dismutase modulatorsKATP channels activators
TargetsKATP channelsSuperoxide dismutase
Therapy Area/IndicationsReperfusion InjuryKidney DiseasesGlaucoma, Open-Angle +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRadikal Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRadikal Therapeutics
Inactive CompaniesN/A
Active IndicationsReperfusion InjuryKidney DiseasesGlaucoma, Open-Angle +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A